揭示硫化氢:神经保护和神经调节的新前沿。

IF 1.6 Q4 BIOCHEMISTRY & MOLECULAR BIOLOGY
Indian Journal of Clinical Biochemistry Pub Date : 2025-10-01 Epub Date: 2024-11-11 DOI:10.1007/s12291-024-01278-w
Ghizal Fatima, Abbas Ali Mahdi, Hekmat B Alhmadi, Oleg Medvedev
{"title":"揭示硫化氢:神经保护和神经调节的新前沿。","authors":"Ghizal Fatima, Abbas Ali Mahdi, Hekmat B Alhmadi, Oleg Medvedev","doi":"10.1007/s12291-024-01278-w","DOIUrl":null,"url":null,"abstract":"<p><p>Hydrogen sulfide (H<sub>2</sub>S), once recognized as a harmful gas, is now emerging as a very significant biological substance with great emphasis on neuroprotection and neuromodulation. It has several functions within the nervous system, placing its physiological activities, biochemical characteristics as well as therapeutic possibilities to their proper perspective. Endogenously produced by cystathione beta-synthase (CBS), cystathione gamma-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (3-MST) enzymes, H<sub>2</sub>S is a unique naturally occurring substance that contains multiple biological activities; it is anti-inflammatory, antioxidant, and anti-apoptotic. Such activity allows H<sub>2</sub>S to reduce oxidative stress, which limits mechanisms of cell death and prevents disruption of mitochondria and thus neuronal injury. H<sub>2</sub>S can also be regarded as a neuromodulator because it interacts with and affects the glutamatergic, dopaminergic and GABAergic systems at the synaptic level as well as on neurotransmitter systems and synapse dynamics. It modulates synaptic transmission and its plasticity which is essential for cognitive as well as motor activities and exhibits anti-inflammatory effects which are helpful in the progress of the neurodegenerative condition. Recently gathered some evidence emphasizes as well the possible use of H<sub>2</sub>S in therapeutic interventions in Alzheimer's disease, Parkinson's disease and stroke. In the models of Alzheimer's disease, H<sub>2</sub>S is able to reduce the toxicity of amyloid-beta peptides and improve cognitive performance. In Parkinson's disease, it protects dopaminergic neurons and reduces the severity of motor deficits. Moreover, H<sub>2</sub>S provides protection in ischemic stroke models through decrease of reactive oxygen species and inflammation. Clinical practice with H<sub>2</sub>S-based therapies seems to have certain hurdles even if preclinical results are promising. Aside from stabilizing H<sub>2</sub>S in a biologically active form, developing a delivery system for H<sub>2</sub>S appears a challenge as well. This review will attempt to summarize the existing studies on H<sub>2</sub>S as neuroprotective and neuromodulatory agents, and their avenues of future use and development.</p>","PeriodicalId":13280,"journal":{"name":"Indian Journal of Clinical Biochemistry","volume":"40 4","pages":"540-550"},"PeriodicalIF":1.6000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12420554/pdf/","citationCount":"0","resultStr":"{\"title\":\"Unveiling Hydrogen Sulfide: A New Frontier in Neuroprotection and Neuromodulation.\",\"authors\":\"Ghizal Fatima, Abbas Ali Mahdi, Hekmat B Alhmadi, Oleg Medvedev\",\"doi\":\"10.1007/s12291-024-01278-w\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Hydrogen sulfide (H<sub>2</sub>S), once recognized as a harmful gas, is now emerging as a very significant biological substance with great emphasis on neuroprotection and neuromodulation. It has several functions within the nervous system, placing its physiological activities, biochemical characteristics as well as therapeutic possibilities to their proper perspective. Endogenously produced by cystathione beta-synthase (CBS), cystathione gamma-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (3-MST) enzymes, H<sub>2</sub>S is a unique naturally occurring substance that contains multiple biological activities; it is anti-inflammatory, antioxidant, and anti-apoptotic. Such activity allows H<sub>2</sub>S to reduce oxidative stress, which limits mechanisms of cell death and prevents disruption of mitochondria and thus neuronal injury. H<sub>2</sub>S can also be regarded as a neuromodulator because it interacts with and affects the glutamatergic, dopaminergic and GABAergic systems at the synaptic level as well as on neurotransmitter systems and synapse dynamics. It modulates synaptic transmission and its plasticity which is essential for cognitive as well as motor activities and exhibits anti-inflammatory effects which are helpful in the progress of the neurodegenerative condition. Recently gathered some evidence emphasizes as well the possible use of H<sub>2</sub>S in therapeutic interventions in Alzheimer's disease, Parkinson's disease and stroke. In the models of Alzheimer's disease, H<sub>2</sub>S is able to reduce the toxicity of amyloid-beta peptides and improve cognitive performance. In Parkinson's disease, it protects dopaminergic neurons and reduces the severity of motor deficits. Moreover, H<sub>2</sub>S provides protection in ischemic stroke models through decrease of reactive oxygen species and inflammation. Clinical practice with H<sub>2</sub>S-based therapies seems to have certain hurdles even if preclinical results are promising. Aside from stabilizing H<sub>2</sub>S in a biologically active form, developing a delivery system for H<sub>2</sub>S appears a challenge as well. This review will attempt to summarize the existing studies on H<sub>2</sub>S as neuroprotective and neuromodulatory agents, and their avenues of future use and development.</p>\",\"PeriodicalId\":13280,\"journal\":{\"name\":\"Indian Journal of Clinical Biochemistry\",\"volume\":\"40 4\",\"pages\":\"540-550\"},\"PeriodicalIF\":1.6000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12420554/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Indian Journal of Clinical Biochemistry\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1007/s12291-024-01278-w\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/11/11 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q4\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Indian Journal of Clinical Biochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12291-024-01278-w","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/11 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

硫化氢(H2S)曾经被认为是一种有害气体,现在已经成为一种非常重要的生物物质,在神经保护和神经调节方面具有重要的作用。它在神经系统中有几种功能,将其生理活动,生化特征以及治疗可能性置于适当的角度。H2S是一种独特的天然物质,具有多种生物活性,由胱胱甘肽-合成酶(CBS)、胱胱甘肽-裂解酶(CSE)和3-巯基丙酮酸硫转移酶(3-MST)内源性产生。它具有抗炎、抗氧化和抗细胞凋亡的作用。这种活性允许H2S减少氧化应激,从而限制细胞死亡机制,防止线粒体破坏,从而防止神经元损伤。H2S也可以被认为是一种神经调节剂,因为它在突触水平上与谷氨酸能、多巴胺能和gaba能系统相互作用,并影响神经递质系统和突触动力学。它调节突触传递及其可塑性,这对认知和运动活动至关重要,并表现出抗炎作用,有助于神经退行性疾病的进展。最近收集的一些证据也强调了H2S在阿尔茨海默病、帕金森病和中风的治疗干预中的可能应用。在阿尔茨海默病模型中,H2S能够降低淀粉样蛋白-肽的毒性并改善认知能力。在帕金森氏症中,它保护多巴胺能神经元,降低运动缺陷的严重程度。此外,H2S通过减少活性氧和炎症对缺血性脑卒中模型具有保护作用。尽管临床前结果很有希望,但基于h2s的疗法的临床实践似乎存在一定的障碍。除了将H2S稳定在生物活性形式之外,开发H2S输送系统也是一个挑战。本文将对H2S作为神经保护和神经调节剂的研究现状进行综述,并对其未来的应用和开发方向进行展望。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Unveiling Hydrogen Sulfide: A New Frontier in Neuroprotection and Neuromodulation.

Hydrogen sulfide (H2S), once recognized as a harmful gas, is now emerging as a very significant biological substance with great emphasis on neuroprotection and neuromodulation. It has several functions within the nervous system, placing its physiological activities, biochemical characteristics as well as therapeutic possibilities to their proper perspective. Endogenously produced by cystathione beta-synthase (CBS), cystathione gamma-lyase (CSE), and 3-mercaptopyruvate sulfurtransferase (3-MST) enzymes, H2S is a unique naturally occurring substance that contains multiple biological activities; it is anti-inflammatory, antioxidant, and anti-apoptotic. Such activity allows H2S to reduce oxidative stress, which limits mechanisms of cell death and prevents disruption of mitochondria and thus neuronal injury. H2S can also be regarded as a neuromodulator because it interacts with and affects the glutamatergic, dopaminergic and GABAergic systems at the synaptic level as well as on neurotransmitter systems and synapse dynamics. It modulates synaptic transmission and its plasticity which is essential for cognitive as well as motor activities and exhibits anti-inflammatory effects which are helpful in the progress of the neurodegenerative condition. Recently gathered some evidence emphasizes as well the possible use of H2S in therapeutic interventions in Alzheimer's disease, Parkinson's disease and stroke. In the models of Alzheimer's disease, H2S is able to reduce the toxicity of amyloid-beta peptides and improve cognitive performance. In Parkinson's disease, it protects dopaminergic neurons and reduces the severity of motor deficits. Moreover, H2S provides protection in ischemic stroke models through decrease of reactive oxygen species and inflammation. Clinical practice with H2S-based therapies seems to have certain hurdles even if preclinical results are promising. Aside from stabilizing H2S in a biologically active form, developing a delivery system for H2S appears a challenge as well. This review will attempt to summarize the existing studies on H2S as neuroprotective and neuromodulatory agents, and their avenues of future use and development.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Indian Journal of Clinical Biochemistry
Indian Journal of Clinical Biochemistry BIOCHEMISTRY & MOLECULAR BIOLOGY-
CiteScore
4.50
自引率
4.80%
发文量
74
期刊介绍: The primary mission of the journal is to promote improvement in the health and well-being of community through the development and practice of clinical biochemistry and dissemination of knowledge and recent advances in this discipline among professionals, diagnostics industry, government and non-government organizations. Indian Journal of Clinical Biochemistry (IJCB) publishes peer reviewed articles that contribute to the existing knowledge in all fields of Clinical biochemistry, either experimental or theoretical, particularly deal with the applications of biochemistry, molecular biology, genetics, biotechnology, and immunology to the diagnosis, treatment, monitoring and prevention of human diseases. The articles published also include those covering the analytical and molecular diagnostic techniques, instrumentation, data processing, quality assurance and accreditation aspects of the clinical investigations in which chemistry has played a major role, or laboratory animal studies with biochemical and clinical relevance.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信